(Q54594205)

English

Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole. (English)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

Helicobacter pylori

0 references

1 reference

based on heuristic

inferred from title

author name string

H Miwa

1

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

R Ohkura

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

T Murai

3

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

K Sato

4

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

A Nagahara

5

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

S Hirai

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

S Watanabe

7

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

N Sato

8

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

language of work or name

0 references

publication date

1 June 1999

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

13

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

741-746

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00526.X

21 January 2018

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00526.X

21 January 2018

Kinetic studies of Helicobacter pylori urease inhibition by a novel proton pump inhibitor, rabeprazole.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00526.X

21 January 2018

Effect of fasting subjects' posture on 13C-urea breath test for detection of Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00526.X

21 January 2018

Usefulness of the [13C]-urea breath test for detection of Helicobacter pylori infection in fasting patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00526.X

21 January 2018

Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00526.X

21 January 2018

The role of antisecretory drugs in the treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00526.X

21 January 2018

The effect of environmental pH on the proton motive force of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00526.X

21 January 2018

Omeprazole may exert both a bacteriostatic and a bacteriocidal effect on the growth of Helicobacter pylori (NCTC 11637) in vitro by inhibiting bacterial urease activity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00526.X

21 January 2018

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00526.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00526.X

21 January 2018

Identifiers

10.1046/J.1365-2036.1999.00526.X

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/10383502

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54594205&oldid=1565923030"